11:55 AM

Sponsored by: Fast-Tracking Recruitment and Data-Driven Engagement: A Sponsor-Aligned, Patient-First Strategy for Smarter, Faster, Fairer Trials

Recruitment is a persistent challenge in clinical research, and expanding access to sites and patients is key. In this session, IQVIA shares how a sponsor-aligned, patient-first model—blending data science, digital innovation, and site enablement—is redefining recruitment to accelerate enrolment and improve trial outcomes. This approach ensures that, once enrolled, participants receive tailored content to enhance their experience, driving stronger retention and more meaningful results.

12:45 PM

Sponsored by: Bridging the Gap: Unifying Clinical Trial Recruitment

Study-wide recruitment often faces challenges because the process is highly variable and typically managed at the local level, with sites frequently chosen based on pattern and habit rather than strategy. This inconsistent approach often produces inconsistent outcomes. Aligning site selection and enrollment strategies with study goals is the key to achieving reliable results.

3:55 PM

Sponsored by: Innovation in Action: Essential Learnings from a High-Performing Decentralized Phase 3 Trial

A successful sponsor-vendor collaboration requires curiosity, problem-solving, and agility. Join us to learn how Praxis Precision Medicines and Spectrum Clinical partnered to support their first-ever, fully decentralized Phase 3 Essential Tremor study through robust, responsive, and patient-first solutions. With over 700 participants enrolled, this panel discussion will showcase the lessons learned, strategy, and extraordinary accomplishments that set a new benchmark for clinical excellence.

4:20 PM

Sponsored by: The New Front Door to Research: Community Engagement that Enables Radically Improved Access to Trials

This joint presentation showcases a working model for clinical trial access that shifts screening upstream, out of individual protocols and into the community, creating meaningful opportunities for patients, accelerating enrollment, and reducing site burden.

Key points

• Decoupling screening from individual protocols and launching a community health screening program

• Engaging with the community to enable the most qualified participants to have access to studies (often more qualified than participants from a site’s own database)

• Removing screening burden from sites on high screen fail programs

• Insight gained from screening enables understanding of potential enrollment capabilities and study design

• Making a meaningful impact on the communities beyond the clinical trial

Together, these elements create a new “front door” to research.

5:10 PM

Sponsored by: Sprinting the Last Mile: Using Technology to Turn Patient Interest into Enrollment

Digital tools have expanded how trials engage potential participants, but the last mile—connecting interested patients to the right sites—remains a common point of failure. In this session, expert sponsor panelists will share practical perspectives on how technology can strengthen this critical handoff. Drawing on real-world experience, the discussion will explore how a unified, behind-the-scenes infrastructure can reduce missed connections, support consistent execution across studies and countries, and improve enrollment conversion—without changing the patient-facing experience or becoming a vendor pitch.

Learning Objectives

• Identify where patient-to-site handoffs break down in the last mile

• Understand the value of a single backend infrastructure across trials and countries

• See how invisible technology can prevent missed connections and improve conversion

8:00 AM

BREAFAST PRESENTATION OPTION #1:
Sponsored by: Reaching the Unreachable: Proven Strategies You Can Apply to Engage Underserved Populations in Global Clinical Trials

Underserved populations are often excluded from clinical trials, limiting engagement, scientific validity, and real-world relevance. Traditional strategies often rely on outdated assumptions and overlook patient realities. This session reveals proven, globally scalable strategies to engage these communities through real-world data (RWD), behavioral insights, and human-centered approaches—replacing guesswork with precision to accelerate inclusive trial enrollment and shorten study timelines.

8:00 AM

BREAKFAST PRESENTATION OPTION #2:
Sponsored by: From Elusive to Enrolled: A Case Study in Precision Recruitment 

As the pace of innovation accelerates, scientific breakthroughs bring new hope to patients. Effectively including and supporting underrepresented populations is critical for the success of clinical trials designed to benefit these communities. GCI Health’s experts will share their “secret sauce” for building meaningful engagement with niche communities along with a real-world example of its methodology in action through its work with the University of Florida’s traumatic brain injury trial.

8:35 AM

Sponsored by: Missing Enrollment: Is a Leaky Funnel the Culprit? 

Trials are bleeding time and budget—and costing organizations the credibility that business growth depends on. The root of the problem? Enrollment. Slow, fragmented processes cause inaccuracy, waste, and delays that lead to patient dropout. Milliman Contxt can leak-proof your enrollment funnel with instant, interpreted health data to streamline workflows while also reducing risk. Easily tap into our vast claims and prescription data network to pre-qualify and retain patients, slash screen failures, and see repeatable success that builds credibility with key stakeholders.

11:15 AM

Sponsored by: Using AI Agents and Connected EHR/EMR Data to Better Understand Design and Recruitment Challenges

Clinical development often suffers from fragmented data across systems, slowing progress and limiting insights. In this session, Justin North (TriNetX) and Abhishek Chatterjee (Novo Nordisk) share how connected data ecosystems break down silos, enabling real-time insights and streamlined operations. Learn practical strategies and outcomes that accelerate trials and improve decision-making for clinical operations teams. Additionally, discover how leveraging EHR/EMR data can inform effective study design and optimize protocol development for better trial outcomes.

12:30 PM

Sponsored by: Patient and Physician-Driven Recruitment for Rare Disease and Targeted Therapies

This session will highlight how stakeholder-driven models remove access barriers, allowing sites to enroll smaller patient populations more quickly and with greater confidence. It will also demonstrate how tighter patient–provider feedback loops accelerate protocol adjustments and support the re-engagement of previously consented candidates. In addition, the discussion will explore how specialist clinicians and non-trial centers can activate referral pathways that connect eligible patients to centers of excellence beyond traditional recruitment channels.

8:00 AM

BREAKFAST PRESENTATION:
Sponsored by: From Burden to Breakthrough: Innovative Strategies for Site and Patient Support

This presentation explores strategies to strengthen clinical trial site capacity and improve patient engagement. It emphasizes delivering customized solutions through specialized roles that integrate with site teams, flexible resourcing, and operational support across key activities such as prescreening, recruitment, data entry, and remote study visits. Additionally, it highlights the importance of global scalability combined with local expertise, supported by an oversight structure that ensures consistency worldwide. The ultimate goal is to drive measurable improvements in site performance, operational efficiency, patient engagement, and retention, creating a more effective and patient-centric trial experience.

9:00 AM

Sponsored by: The Patient Recruitment Reality Check—Debating 3 of the Biggest Myths in Our Industry

When it comes to patient recruitment, separating fact from fiction isn’t always easy. Joined by experts from Amgen, Bristol Myers Squibb, and Takeda, we’ll explore the 3 biggest myths shaping today’s clinical trial recruitment industry.

Guest speakers:

• Alex Weir, Senior Director & Head of Operational Design, Clinical Program Operations, Amgen

• Michele Falk, Associate Director, R&DD Global Patient Outreach Recruitment Lead, Bristol Myers Squibb

• Amanda Decoker, Senior Director, Head of Patient Engagement, Experience and Recruitment, Takeda

12:00 PM

Sponsored by: Engaging and Retaining Teenagers in Clinical Trials: Co-Designing for the Teen–Caregiver Relationship

This session explores how to build trust & engagement with teenagers in clinical research, and why this depends on the teen–caregiver relationship. Drawing on co-design with teens and caregivers, we share key insights and how these informed a scalable digital solution that improves participation, experience, and retention across therapy areas. The session challenges assumptions about youth engagement, showing how patient-centred design improves diversity and delivers robust, reusable strategies.